University of Michigan

Wolverine Boots Launches First of Its Kind University of Michigan Boot Collection Benefitting Student Athletes

Retrieved on: 
Thursday, October 19, 2023

ROCKFORD, Mich., Oct. 19, 2023 /PRNewswire/ -- Wolverine Boots, the 140-year-old boot maker, is launching two University of Michigan branded boots which will be sold exclusively at The M Den; the University's official athletic merchandise retailer. A limited number of pairs are now available at the Ann Arbor M Den. For each pair sold, Wolverine will be contributing a portion of proceeds to the Champions Circle, the University of Michigan's NIL collective that benefits student athletes, with an additional giveback coming from the M Den.

Key Points: 
  • For each pair sold, Wolverine will be contributing a portion of proceeds to the Champions Circle, the University of Michigan's NIL collective that benefits student athletes, with an additional giveback coming from the M Den.
  • The Wolverine x U of Michigan branded boots are built on the silhouette of Wolverine's popular Floorhand Moc Toe boot.
  • Both colorways feature a waterproof full-grain leather upper, a Wolverine x University of Michigan woven tongue label and embossed University of Michigan 'M' in the heel.
  • The Wolverine x U of Michigan boots launch comes after an already established name, image, likeness (NIL) agreement between Wolverine Boots and 13 University of Michigan football players, including star running back, and 2022 Heisman Trophy finalist, Blake Corum.

Alternative Credentials Market for Higher Education is to grow by USD 2.27 billion from 2022 to 2027, the market is fragmented due to the presence of prominent companies like 2U Inc., Bisk Ventures and Cengage Learning Holdings II Inc., and many more - Te

Retrieved on: 
Wednesday, October 11, 2023

The alternative credentials market for higher education is fragmented owing to the presence of many global and regional companies.

Key Points: 
  • The alternative credentials market for higher education is fragmented owing to the presence of many global and regional companies.
  • Ltd., Strategic Education Inc., Temple University, Udacity Inc., Udemy Inc, University of Michigan, University Professional and Continuing Education Association, and XuetangX.
  • The report provides a full list of key companies, their strategies, and the latest developments.
  • Bisk Ventures - The company offers alternative credentials with innovative use of technology to engage students in impactful learning experiences and to strengthen education to employment pathways.

Clark Atlanta University's Executive Leadership Institute Continues To Shape The Future Of HBCUs

Retrieved on: 
Thursday, October 5, 2023

ATLANTA, Oct. 4, 2023 /PRNewswire/ -- The HBCU Executive Leadership Institute (HBCU ELI) at Clark Atlanta University is now accepting applications for its 2024 Community Fellows, with an October 19, 2023 deadline. Aspiring leaders with a passion for shaping the future of Historically Black Colleges and Universities (HBCUs) are encouraged to apply online today.

Key Points: 
  • ATLANTA, Oct. 4, 2023 /PRNewswire/ -- The HBCU Executive Leadership Institute (HBCU ELI) at Clark Atlanta University is now accepting applications for its 2024 Community Fellows, with an October 19, 2023 deadline.
  • Aspiring leaders with a passion for shaping the future of Historically Black Colleges and Universities (HBCUs) are encouraged to apply online today.
  • From operations and budgeting to academics, fundraising, development, board governance, and the pursuit of racial and social justice, ELI covers every aspect of HBCU leadership.
  • ELI continues to honor this legacy, preserving and strengthening HBCUs as hubs of education, opportunity, and uplift in the communities they serve.

HOW WOMEN LEAD ANNOUNCES THE 2023 #GETONBOARDWEEK HONOREES

Retrieved on: 
Wednesday, October 4, 2023

SAN FRANCISCO, Oct. 4, 2023 /PRNewswire/ -- How Women Lead, a powerful community of more than 20,000 accomplished women executives working to redefine female leadership in the 21st century, today announced the winners of its fourth annual #GetOnBoardWeek Awards. The awards recognize people and companies for their impactful work creating more equity for women in the workplace. The award ceremony will take place on Wednesday, October 18th during How Women Lead's #GetOnBoardWeek.

Key Points: 
  • Over the span of five days, #GetOnBoardWeek will feature 150+ women corporate board directors discussing cutting-edge board topics on becoming a more compelling and effective board director to over 2,000 women.
  • "I'm so excited to honor such inspiring women during this year's #GetOnBoardWeek," said Julie Castro Abrams, Founder and CEO of How Women Lead.
  • She embodies the How Women Lead Credo by being a fierce advocate for other women—she's a culture-changer in that regard.
  • The 2023 #GetOnBoardWeek award honorees are:
    Robin Washington is the recipient of this year's Fearless Leader Award, which honors women who have made significant strides in promoting women on board and in executive leadership positions.

Marathon Runners Take to the Windy City to Raise Awareness of Liver Disease

Retrieved on: 
Wednesday, October 4, 2023

FAIRFIELD, N.J., Oct. 4, 2023 /PRNewswire/ -- The American Liver Foundation (ALF) is proud to once again be a member of the Bank of America Chicago Marathon Official Charity Program for the 2023 race, which takes place on Sunday, October 8, 2023, in iconic Grant Park.

Key Points: 
  • "There are nearly 100 million people in the U.S. affected by liver disease, and most aren't aware they even have it.
  • That's why we are so honored that these runners have chosen to join us to help raise awareness and funds to combat liver disease."
  • The American Liver Foundation's Bank of America Chicago Marathon team has already met their fundraising goal and has since increased it.
  • The American Liver Foundation team is made up of runners with varying levels of experience from novice to advanced, most of whom have a connection to liver disease.

Southern Michigan Bancorp and Southern Michigan Bank & Trust Announce Leadership Transition

Retrieved on: 
Tuesday, October 3, 2023

COLDWATER, Mich., Oct. 03, 2023 (GLOBE NEWSWIRE) -- After decades of leadership and service, CEO John Castle and President Kurt Miller are planning to retire from Southern Michigan Bancorp and Southern Michigan Bank & Trust.

Key Points: 
  • COLDWATER, Mich., Oct. 03, 2023 (GLOBE NEWSWIRE) -- After decades of leadership and service, CEO John Castle and President Kurt Miller are planning to retire from Southern Michigan Bancorp and Southern Michigan Bank & Trust.
  • Southern will continue to be headquartered in Coldwater, as it has been since its founding in 1872.
  • “Combined, they have a near century of knowledge and commitment to the success of Southern, which has benefited tremendously from their leadership.
  • Grabowski joined Southern in 2003 and has held leadership roles in managed assets and commercial lending before stepping into the bank’s top lending role.

WARC releases The Future of Strategy 2023, a worldwide survey-led report with insights from almost 1,000 marketing strategists

Retrieved on: 
Tuesday, October 3, 2023

These are some of the findings included in The Future of Strategy 2023 report released today by WARC - the global authority on marketing effectiveness.

Key Points: 
  • These are some of the findings included in The Future of Strategy 2023 report released today by WARC - the global authority on marketing effectiveness.
  • This eleventh edition of the annual WARC study unpacks the key trends considered pivotal to the future of strategy.
  • Lena Roland, Head of Content, WARC Strategy, says: "Our annual Future of Strategy report acts as a temperature check for how strategists are feeling about the state of the discipline.
  • The Future of Strategy 2023 report, which includes quantitative and qualitative data analysis, expert commentary and advice from leading strategists, is available to WARC subscribers.

Cruise, University of Michigan Transportation Research Institute present groundbreaking study establishing a human driving safety benchmark

Retrieved on: 
Wednesday, September 27, 2023

SAN FRANCISCO, Sept. 27, 2023 /PRNewswire/ -- Cruise and The University of Michigan Transportation Research Institute, one of the leading transportation research institutes in the country, partnered to create a human benchmark to be used in measuring safety performance of autonomous vehicles in San Francisco. This research, conducted in collaboration with General Motors and the Virginia Tech Transportation Institute (VTTI), offers a nuanced safety performance measure to use for Cruise's driverless fleet.

Key Points: 
  • SAN FRANCISCO, Sept. 27, 2023 /PRNewswire/ -- Cruise and The University of Michigan Transportation Research Institute, one of the leading transportation research institutes in the country, partnered to create a human benchmark to be used in measuring safety performance of autonomous vehicles in San Francisco.
  • This research, conducted in collaboration with General Motors and the Virginia Tech Transportation Institute (VTTI), offers a nuanced safety performance measure to use for Cruise's driverless fleet.
  • This study allows us to be more precise about the statistics originally released in our 1 million mile report .
  • "What's been missing in autonomous vehicle research is a benchmark that goes beyond the available data and accurately reflects the human driver.

BD² ANNOUNCES RESEARCH AND CLINICAL NETWORK TO ADVANCE TREATMENT FOR BIPOLAR DISORDER

Retrieved on: 
Wednesday, September 27, 2023

WASHINGTON, Sept. 27, 2023 /PRNewswire/ -- BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder today announced the first six institutions that will launch the groundbreaking BD² Integrated Network. Brigham and Women's Hospital-McLean Hospital, University of California Los Angeles, Johns Hopkins University, Mayo Clinic, University of Michigan, and UTHealth Houston together comprise the first sites that will work in partnership with clinicians, researchers, and people living with bipolar disorder to expand knowledge of bipolar disorder while accelerating the translation of that knowledge into clinical care. The BD² Integrated Network integrates clinical, behavioral, and biological data to gain new insight into bipolar disorder and accelerate improved treatment. Over the next five years, it will engage 4,000 people living with bipolar disorder as part of a longitudinal cohort study.

Key Points: 
  • The BD² Integrated Network integrates clinical, behavioral, and biological data to gain new insight into bipolar disorder and accelerate improved treatment.
  • Over the next five years, it will engage 4,000 people living with bipolar disorder as part of a longitudinal cohort study.
  • "For too long, there have been limited breakthroughs in the study and treatment of bipolar disorder," said Cara Altimus, PhD, managing director for BD² and senior director at the Milken Institute.
  • "Current understanding of the mechanisms of bipolar disorder are inadequate to meet the needs of individuals living with bipolar disorder today," said Mark Frye, MD, BD² Integrated Network scientific director.

Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)

Retrieved on: 
Tuesday, September 26, 2023

THE WOODLANDS, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced several upcoming Lexicon-supported data presentations related to heart failure (HF), type 1 diabetes (T1D), and diabetic peripheral neuropathic pain (DPNP). The oral presentations will be made at the 59th Annual Meeting of EASD, October 2-6, 2023, in Hamburg, Germany and online.

Key Points: 
  • The oral presentations will be made at the 59th Annual Meeting of EASD, October 2-6, 2023, in Hamburg, Germany and online.
  • Lexicon is preparing to advance LX9211 into late-stage development in a clinical program directed towards an application for regulatory approval in DPNP.
  • The first late-stage study will be a Phase 2b dose optimization study, with study planning underway and initiation of dosing expected before the end of 2023.
  • “These presentations at EASD will help generate greater awareness of these programs and their potential to help patients across various therapeutic areas.”